Audit 395231

FY End
2025-06-30
Total Expended
$374.71M
Findings
3
Programs
206
Organization: Wake Forest University (NC)
Year: 2025 Accepted: 2026-03-27
Auditor: KPMG LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1190945 2025-002 Material Weakness Yes N
1190946 2025-002 Material Weakness Yes N
1190947 2025-002 Material Weakness Yes N

Programs

ALN Program Spent Major Findings
84.268 FEDERAL DIRECT STUDENT LOANS $54.75M Yes 1
93.RD Lung Organ Tissue Equivalent Platform For Modeling Chlorine Gas Toxicology: $6.82M Yes 0
14.251 ECONOMIC DEVELOPMENT INITIATIVE, COMMUNITY PROJECT FUNDING, AND MISCELLANEOUS GRANTS $4.64M Yes 0
84.063 FEDERAL PELL GRANT PROGRAM $4.14M Yes 0
84.038 FEDERAL PERKINS LOAN PROGRAM_FEDERAL CAPITAL CONTRIBUTIONS $3.77M Yes 1
93.493 CONGRESSIONAL DIRECTIVES $2.25M Yes 0
93.917 HIV CARE FORMULA GRANTS $1.81M Yes 0
93.RD Organ Tissue Equivalent (OTE) Platform for Vaccine Testing $1.55M Yes 0
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $1.42M Yes 0
20.614 NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION (NHTSA) DISCRETIONARY SAFETY GRANTS AND COOPERATIVE AGREEMENTS $1.41M Yes 0
93.RD Fibrosis 2.0 study $1.30M Yes 0
98.001 USAID FOREIGN ASSISTANCE FOR PROGRAMS OVERSEAS $1.22M Yes 0
12.RD CONSORT $959,487 Yes 0
93.958 BLOCK GRANTS FOR COMMUNITY MENTAL HEALTH SERVICES $883,861 Yes 0
93.RD Women Health Initiative - Regional Center $864,613 Yes 0
47.049 MATHEMATICAL AND PHYSICAL SCIENCES $760,402 Yes 0
12.630 BASIC, APPLIED, AND ADVANCED RESEARCH IN SCIENCE AND ENGINEERING $722,195 Yes 0
93.918 GRANTS TO PROVIDE OUTPATIENT EARLY INTERVENTION SERVICES WITH RESPECT TO HIV DISEASE $666,913 Yes 0
84.033 FEDERAL WORK-STUDY PROGRAM $659,521 Yes 0
84.007 FEDERAL SUPPLEMENTAL EDUCATIONAL OPPORTUNITY GRANTS $638,869 Yes 0
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $635,368 Yes 0
93.253 POISON CENTER SUPPORT AND ENHANCEMENT GRANT $622,526 Yes 0
16.001 LAW ENFORCEMENT ASSISTANCE NARCOTICS AND DANGEROUS DRUGS LABORATORY ANALYSIS $579,656 Yes 0
93.RD (VISION) Strategies for Whole Eye Transplant $521,310 Yes 0
27.011 INTERGOVERNMENTAL PERSONNEL ACT (IPA) MOBILITY PROGRAM $512,917 Yes 0
93.084 PREVENTION OF DISEASE, DISABILITY, AND DEATH BY INFECTIOUS DISEASES $505,849 Yes 0
93.RD Community-Based Capacity Restoration Planning $483,815 Yes 0
93.RD Survelliance of Acutely III Adults with Respiratory Virus Sars Cov 2 $467,933 Yes 0
12.RD Chilled Platelet Study $449,325 Yes 0
43.RD Space Operations $448,467 Yes 0
12.RD Assembly of Topologic $440,535 Yes 0
12.RD Development of Gel for Prevention of Combat-Related Infections $427,022 Yes 0
93.928 SPECIAL PROJECTS OF NATIONAL SIGNIFICANCE $410,876 Yes 0
93.RD ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) FIELD CENTER $410,408 Yes 0
12.RD Determining The Fundamental Differences Among Tissue Org $402,722 Yes 0
93.173 RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS $365,777 Yes 0
93.867 VISION RESEARCH $337,277 Yes 0
12.340 NAVAL MEDICAL RESEARCH AND DEVELOPMENT $336,991 Yes 0
93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS $333,883 Yes 0
81.049 OFFICE OF SCIENCE FINANCIAL ASSISTANCE PROGRAM $290,487 Yes 0
93.RD ELC Project K8 Threat of Antibiotic-Resistant Gonorrhea: $283,357 Yes 0
93.837 CARDIOVASCULAR DISEASES RESEARCH $282,872 Yes 0
93.RD Advanced Research and Development of Regulatory Science $281,605 Yes 0
93.879 MEDICAL LIBRARY ASSISTANCE $248,048 Yes 0
47.070 COMPUTER AND INFORMATION SCIENCE AND ENGINEERING $244,772 Yes 0
93.RD The Atherosclerosis Risk in Communities (ARIC) Study Field Center $241,048 Yes 0
21.027 CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS $239,484 Yes 0
93.113 ENVIRONMENTAL HEALTH $235,290 Yes 0
93.994 MATERNAL AND CHILD HEALTH SERVICES BLOCK GRANT TO THE STATES $219,362 Yes 0
12.RD Military-Civilian Prehospital Burn Provider Education Research Program $191,280 Yes 0
93.003 PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND $179,677 Yes 0
93.RD Development of a model to assess maternal antibody $177,608 Yes 0
12.351 SCIENTIFIC RESEARCH - COMBATING WEAPONS OF MASS DESTRUCTION $168,100 Yes 0
93.RD REBOA- Rahbar/Jordan TexasAM $166,533 Yes 0
16.575 CRIME VICTIM ASSISTANCE $162,446 Yes 0
93.RD Targeting ceramide metabolism in AML $154,449 Yes 0
93.RD Fungal Translocation in Chronic Obstructive Pulmonary Disease $150,785 Yes 0
93.121 ORAL DISEASES AND DISORDERS RESEARCH $145,671 Yes 0
12.RD Human Microengineered Organ Tissue Equivalents for Modeling the Effects of Chemical Agents $144,385 Yes 0
93.RD Multi-component CRC screening intervention effectiveness $141,933 Yes 0
93.RD Simult. mRNA COVID-19 & IIV4 Vaccine $134,994 Yes 0
47.076 STEM EDUCATION (FORMERLY EDUCATION AND HUMAN RESOURCES) $133,470 Yes 0
93.107 AREA HEALTH EDUCATION CENTERS $128,288 Yes 0
93.361 NURSING RESEARCH $126,398 Yes 0
93.069 PUBLIC HEALTH EMERGENCY PREPAREDNESS $123,730 Yes 0
93.286 DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH $122,615 Yes 0
93.110 MATERNAL AND CHILD HEALTH FEDERAL CONSOLIDATED PROGRAMS $115,627 Yes 0
93.RD Multi-Ethnic Study of Atherosclerosis (MESA) $114,105 Yes 0
12.RD Partially Automated Critical Care Management PACCMAN Refinement $112,445 Yes 0
47.050 GEOSCIENCES $106,694 Yes 0
93.RD Training and Implementation Resources for the ChiCAS $97,498 Yes 0
12.431 BASIC SCIENTIFIC RESEARCH $92,891 Yes 0
66.475 GEOGRAPHIC PROGRAMS – GULF OF MEXICO PROGRAM $92,865 Yes 0
93.978 SEXUALLY TRANSMITTED DISEASES (STD) PROVIDER EDUCATION GRANTS $90,290 Yes 0
12.007 MILITARY HEALTH SERVICES RESEARCH (MHSR) $88,404 Yes 0
93.250 GERIATRIC ACADEMIC CAREER AWARDS DEPARTMENT OF HEALTH AND HUMAN SERVICES $86,562 Yes 0
93.RD Atherosclerosis Risk in Communities (ARIC) Study - Coordinating Center: $85,300 Yes 0
93.RD Jackson Heart Study $83,307 Yes 0
93.242 MENTAL HEALTH RESEARCH GRANTS $80,746 Yes 0
93.RD Heartshare Data - RTI International $74,742 Yes 0
93.RD REGARDS in-home visit $73,109 Yes 0
47.083 INTEGRATIVE ACTIVITIES $70,918 Yes 0
12.RD Advanced Ballistics Technology: Material Development, Characterization and Computational Modeling $69,109 Yes 0
93.136 INJURY PREVENTION AND CONTROL RESEARCH AND STATE AND COMMUNITY BASED PROGRAMS $68,113 Yes 0
93.RD Jackson Heart Surveillance Study (JHS Surveilliance): $63,885 Yes 0
93.839 BLOOD DISEASES AND RESOURCES RESEARCH $63,564 Yes 0
10.310 AGRICULTURE AND FOOD RESEARCH INITIATIVE (AFRI) $62,852 Yes 0
93.RD Modeling equity impact of age restrictedlocation policies $60,687 Yes 0
93.172 HUMAN GENOME RESEARCH $57,662 Yes 0
93.124 NURSE ANESTHETIST TRAINEESHIP $55,620 Yes 0
93.334 THE HEALTHY BRAIN INITIATIVE: TECHNICAL ASSISTANCE TO IMPLEMENT PUBLIC HEALTH ACTIONS RELATED TO COGNITIVE HEALTH, COGNITIVE IMPAIRMENT, AND CAREGIVING AT THE STATE AND LOCAL LEVELS $55,451 Yes 0
93.RD Shade_Duke_Main Preventable Study $54,129 Yes 0
93.583 REFUGEE AND ENTRANT ASSISTANCE WILSON/FISH PROGRAM $52,351 Yes 0
93.RD Harm Reduction Among Patients Experiencing Human Trafficking $50,000 Yes 0
93.310 TRANS-NIH RESEARCH SUPPORT $48,166 Yes 0
93.RD Subcontract for Strategies and Treatments for Respiratory and Viral Emergencies Study Payments (STRIVE) $47,870 Yes 0
84.336 TEACHER QUALITY PARTNERSHIP GRANTS $46,822 Yes 0
93.RD Tele-COPD $46,694 Yes 0
93.323 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) $46,142 Yes 0
93.211 TELEHEALTH PROGRAMS $44,613 Yes 0
93.RD PROMOTE $43,566 Yes 0
64.RD Structural & Functional Neurobiology of Veterans Grants: $43,044 Yes 0
43.003 EXPLORATION $41,971 Yes 0
93.397 CANCER CENTERS SUPPORT GRANTS $41,100 Yes 0
93.153 COORDINATED SERVICES AND ACCESS TO RESEARCH FOR WOMEN, INFANTS, CHILDREN, AND YOUTH $39,870 Yes 0
93.273 ALCOHOL RESEARCH PROGRAMS $38,475 Yes 0
47.074 BIOLOGICAL SCIENCES $37,890 Yes 0
93.889 NATIONAL BIOTERRORISM HOSPITAL PREPAREDNESS PROGRAM $36,854 Yes 0
10.331 GUS SCHUMACHER NUTRITION INCENTIVE PROGRAM $35,793 Yes 0
93.RD OPICO $35,055 Yes 0
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $30,830 Yes 0
93.351 RESEARCH INFRASTRUCTURE PROGRAMS $29,328 Yes 0
47.RD NASA Awards $29,184 Yes 0
93.396 CANCER BIOLOGY RESEARCH $28,655 Yes 0
93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH $27,392 Yes 0
93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH $26,725 Yes 0
93.840 TRANSLATION AND IMPLEMENTATION SCIENCE RESEARCH FOR HEART, LUNG, BLOOD DISEASES, AND SLEEP DISORDERS $25,074 Yes 0
47.075 SOCIAL, BEHAVIORAL, AND ECONOMIC SCIENCES $24,663 Yes 0
12.RD Driving Pressure-Limited Ventilation in Hpoxemic Respiratory Failure $24,315 Yes 0
93.RD Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity $23,466 Yes 0
93.073 BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES - PREVENTION AND SURVEILLANCE $22,434 Yes 0
45.149 PROMOTION OF THE HUMANITIES DIVISION OF PRESERVATION AND ACCESS $22,137 Yes 0
93.RD Soliman_Strong Heart Study $21,019 Yes 0
81.RD Assessing Environmental and Health Impacts $20,923 Yes 0
93.912 RURAL HEALTH CARE SERVICES OUTREACH, RURAL HEALTH NETWORK DEVELOPMENT AND SMALL HEALTH CARE PROVIDER QUALITY IMPROVEMENT $19,733 Yes 0
93.233 NATIONAL CENTER ON SLEEP DISORDERS RESEARCH $19,346 Yes 0
93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT $19,311 Yes 0
93.433 ACL NATIONAL INSTITUTE ON DISABILITY, INDEPENDENT LIVING, AND REHABILITATION RESEARCH $18,675 Yes 0
93.945 ASSISTANCE PROGRAMS FOR CHRONIC DISEASE PREVENTION AND CONTROL $16,425 Yes 0
93.080 BLOOD DISORDER PROGRAM: PREVENTION, SURVEILLANCE, AND RESEARCH $16,406 Yes 0
93.RD HTN study $16,331 Yes 0
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $15,668 Yes 0
93.RD Substance misuse and pain management in the Lumbee Tribe $15,630 Yes 0
12.RD Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury $14,776 Yes 0
93.RD CHS Research for the Cardiovascular Health of Older Adul18295 $14,548 Yes 0
93.318 PROTECTING AND IMPROVING HEALTH GLOBALLY: BUILDING AND STRENGTHENING PUBLIC HEALTH IMPACT, SYSTEMS, CAPACITY AND SECURITY $13,666 Yes 0
93.RD Impact of Nicotine Reduction on Adolescent Cigarette Use: $13,640 Yes 0
12.RD Regenerative Rehabilitation for Complex Musculoskeletal Trauma $13,634 Yes 0
93.398 CANCER RESEARCH MANPOWER $13,152 Yes 0
47.041 ENGINEERING $12,780 Yes 0
93.262 OCCUPATIONAL SAFETY AND HEALTH PROGRAM $12,317 Yes 0
93.399 CANCER CONTROL $12,256 Yes 0
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $12,227 Yes 0
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $11,540 Yes 0
93.RD Combination Anti-amyloid Therapy for Preclinical Alzheim $10,656 Yes 0
10.216 1890 INSTITUTION CAPACITY BUILDING GRANTS $10,479 Yes 0
84.425 EDUCATION STABILIZATION FUND $10,102 Yes 0
93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH $10,065 Yes 0
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $10,053 Yes 0
93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH $10,048 Yes 0
93.989 INTERNATIONAL RESEARCH AND RESEARCH TRAINING $9,449 Yes 0
47.084 NSF TECHNOLOGY, INNOVATION, AND PARTNERSHIPS $8,723 Yes 0
93.RD MAIN-CAV-Randomized Trial of Maintainance Cabozantinib and Avelumab $8,429 Yes 0
93.RD Klepin and Southwest Oncology Group for CTSU S2114 $8,416 Yes 0
93.RD Phase III Trial of Stereotactic Radiosurgery (SRS) $8,148 Yes 0
94.013 AMERICORPS VOLUNTEERS IN SERVICE TO AMERICA 94.013 $8,128 Yes 0
93.393 CANCER CAUSE AND PREVENTION RESEARCH $7,814 Yes 0
93.RD Regulation and Function of Very Long Chain Fatty Acid Biosynthesis $7,465 Yes 0
93.924 RYAN WHITE HIV/AIDS DENTAL REIMBURSEMENT AND COMMUNITY BASED DENTAL PARTNERSHIP GRANTS $6,864 Yes 0
93.RD High Risk Prostate Cancer Evaluating $6,831 Yes 0
93.RD STEP $6,438 Yes 0
93.RD Exploration of bioactive components in Hawaiian mamaki tea $6,252 Yes 0
93.226 RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES $6,088 Yes 0
93.008 MEDICAL RESERVE CORPS SMALL GRANT PROGRAM $5,278 Yes 0
93.RD NCI MYELOMATCH CLINICAL TRIALS $5,245 Yes 0
93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES $5,177 Yes 0
93.421 STRENGTHENING PUBLIC HEALTH SYSTEMS AND SERVICES THROUGH NATIONAL PARTNERSHIPS TO IMPROVE AND PROTECT THE NATION’S HEALTH $5,147 Yes 0
84.220 CENTERS FOR INTERNATIONAL BUSINESS EDUCATION $4,515 Yes 0
12.800 AIR FORCE DEFENSE RESEARCH SCIENCES PROGRAM $4,235 Yes 0
12.RD ABRUPT2 $4,213 Yes 0
93.838 LUNG DISEASES RESEARCH $4,025 Yes 0
93.RD NRG BN012 $4,025 Yes 0
93.RD Jagosky Megan NCI $3,908 Yes 0
45.312 NATIONAL LEADERSHIP GRANTS $3,862 Yes 0
93.RD Massive Transfusion in Children II MATIC 2 $3,687 Yes 0
93.103 FOOD AND DRUG ADMINISTRATION RESEARCH $3,482 Yes 0
43.001 SCIENCE $3,273 Yes 0
93.RD Cancer Research $3,075 Yes 0
93.RD Primary Lung Tumor Stereotactic Body Radiation Therapy $3,004 Yes 0
12.RD Novel Topical Antibiotic Therapy $2,632 Yes 0
93.395 CANCER TREATMENT RESEARCH $2,620 Yes 0
93.RD Optimal Perioperative Therapy For Incidental Gallbladder $2,445 Yes 0
93.RD Venetoclax and HMA-Based Therapies for Leukemia $2,064 Yes 0
93.RD A Randomized Phase II/III Study of Conventional $2,014 Yes 0
93.RD Randomized Phase III Trial of Bortezomib Lenalidomide a $1,946 Yes 0
93.RD Randomized Phase III Study of Ibrutinib (PCI-32765)-based Therapy: $1,902 Yes 0
84.379 TEACHER EDUCATION ASSISTANCE FOR COLLEGE AND HIGHER EDUCATION GRANTS (TEACH GRANTS) $1,886 Yes 0
93.127 EMERGENCY MEDICAL SERVICES FOR CHILDREN $1,858 Yes 0
93.RD Evaluating Fitness-for-Use of Electronic Health Records $1,418 Yes 0
43.007 SPACE OPERATIONS $1,410 Yes 0
93.RD Change in Relative Cerebral Blood Volume as a Biomarker: $1,250 Yes 0
93.RD Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs $1,012 Yes 0
93.RD A Randomized Phase II/III Trial of Modern Immunotherapy $996 Yes 0
93.RD Phase II Study of DaratumumabHyaluronidase $968 Yes 0
93.RD Strata STEPs $858 Yes 0
12.300 BASIC AND APPLIED SCIENTIFIC RESEARCH $775 Yes 0
93.RD Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT $509 Yes 0
93.RD STEP - Master Protocol $457 Yes 0
93.RD Phase II Study of Venetoclax Plus Chemotherapy forLeukemia: A Tier 1 MYELOMATCH Clinical Trial $258 Yes 0
93.RD Phase III Trial of Perioperative Immunotherapy for Stage III IV Cutaneous Squamous Cell Carcinoma $79 Yes 0
45.310 GRANTS TO STATES $-19 Yes 0
12.RD National Clinical Trials Network $-50 Yes 0
93.969 PPHF GERIATRIC EDUCATION CENTERS $-149 Yes 0
93.077 FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT REGULATORY RESEARCH $-3,581 Yes 0
93.213 RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH $-11,032 Yes 0
93.866 AGING RESEARCH $-13,620 Yes 0

Contacts

Name Title Type
MBU6HCLNZ431 Marnie Matthews Auditee
3367583201 Alison Upton Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards (the schedule) includes all grants, contracts, and similar agreements entered into directly between Wake Forest University (the University) and agencies and departments of the federal government and all subawards to the University by nonfederal organizations pursuant to federal grants, contracts, and similar agreements and is presented on the accrual basis of accounting. The information in the schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. The accompanying schedule of expenditures of state awards includes all grants, contracts, and similar agreements entered into directly between the University and agencies and departments of the state government and all subawards to the University by nonfederal organizations pursuant to state grants, contracts, and similar agreements and is presented on the accrual basis of accounting.
Expenditures for certain federal student financial aid programs are recognized as incurred and include the federal share of students’ Federal Supplemental Educational Opportunity Grant (FSEOG) program grants and Federal Work Study (FWS) program earnings, Pell grants, loan disbursements, and administrative cost allowances, where applicable. Expenditures for other federal awards of the University’s academic and other divisions are determined using the cost principles contained in Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Expenditures for non-financial aid awards include indirect costs, related primarily to facilities operation and maintenance and general, divisional, and departmental administrative services, which are allocated to direct cost objectives (including federal awards) based on negotiated formulas commonly referred to as facilities and administrative cost rates. Facilities and administrative costs allocated to such awards for the year ended June 30, 2025 were based on predetermined rates negotiated with the University’s cognizant federal agency, the U.S. Department of Health and Human Services. The University has elected not to use the de minimis indirect cost rate as allowed under the Uniform Guidance Section 200.414. Negative balances presented in the schedule represent programs with unfunded expenditures prior to normal close-out procedures, which were subsequently transferred to nonfederal cost centers.
The Federal Perkins Loan program is administered directly by the University and balances and transactions relating to the program are included in the University’s consolidated financial statements. The balance of loans outstanding under the Federal Perkins Loan program was $2,599,615 as of June 30, 2025. The University disbursed the following amounts of new loans under the Federal Direct Student Loan Program to students of the University during the year ended June 30, 2025: Federal Direct Student Loan Program: Federal subsidized stafford loans $ 1,533,543 Federal unsubsidized stafford loans 47,913,651 Federal PLUS loans 46,848,511 Total $ 96,295,705 The University is responsible only for the performance of certain administrative duties with respect to the Federal Direct Student Loan Program and, accordingly, these loans are not included in its basic financial statements. It is not practicable to determine the balance of loans outstanding to students and former students of the University under these programs as of June 30, 2025.

Finding Details

Finding 2025-002: NSLDS Reporting Federal Agency U.S. Department of Education Federal Program Student Financial Assistance Cluster (ALN # 84.268, 84.063) Federal Award Year July 1, 2024 through June 30, 2025 Federal Award Numbers P063P241963; P268K251963; P268K256998; P268K256953; P268K258670; P268K256952 Criteria or Requirement Per Sections 34 CFR 690.83(b)(2) and 34 CFR 685.309, a school shall update the student status confirmation report for changes in student status, report the date the enrollment status was effective and return the student status confirmation report to the Secretary within 30 days unless it plans to submit an enrollment report within the next 60 days of receipt. Per Sections 4.4.2 through 4.4.4 of the NSLDS enrollment reporting guide, institutions are responsible for accurately reporting all Campus-Level Record data elements and considers certain data elements to be high risk including OPEID Number, Enrollment Effective Date, Enrollment Status, and Certification Date. Per Section 4.4.8 of the NSLDS enrollment reporting guide, institutions are responsible for accurately reporting all Program-Level Record data elements and considers certain data elements to be high risk including OPEID Number, CIP Code, CIP Year, Credential Level, Published Program Length Measurement, Published Program Length, Program Begin Date, Program Enrollment Status, and Program Enrollment Effective Date. Per 2 CFR 200.303, the non-Federal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. Condition Found For 22 out of the 520 data elements tested across a sample of 40 students, the data element was not reported accurately. The data elements not reported accurately included the student's enrollment status, OPEID number, program-level effective date, and the published program length. There were no exceptions related to the timeliness of NSLDS reporting identified. • For 1 out of 40 students, the student’s status was inaccurately reported as Withdrawn while studying abroad rather than Full-time at both the Campus-Level Record and the Program-Level Record. • For 8 out of 40 students, the incorrect OPEID Number was reported. • For 2 out of 40 students who had a status change from Withdrawn to Full-time, the effective date of the status change was not reported accurately within the Program-Level Record. The effective date was reported as 7/5/2022 rather than 2/10/2025. • For 7 out of 40 students, the effective date for the Graduated status reported to NSLDS at the Program-Level Record did not match the Campus-Level Record by 1-9 days. • For 2 out of 40 students, the effective date for the Half-time status reported to NSLDS at the Program- Level Record did not match the Campus-Level Record by 23-49 days. • For 1 out of 40 students, the Published Program Length was reported at 1.5 years rather than 1.1 years. Possible Cause and Asserted Effect The control that management reviews all reports for the accuracy of all data elements prior to submission was not operating at a level to ensure that enrollment status, enrollment effective date, published program length, and OPEID number were accurately and consistently reported to NSLDS. Questioned Costs None identified. Sampling The sample was not intended to be, and was not, a statistically valid sample. Identification of Whether the Audit Finding is a Repeat of a Finding in the Immediately Prior Audit No. Recommendation We recommend the University enhance the precision of the control around the review of accuracy of the enrollment statuses, program level data records, and campus level data records within the NSLDS reporting submissions. Views of Responsible Officials The University agrees with the finding and recommendation to enhance the precision of the control around the review of accuracy of the enrollment statuses, program level data records, and campus level data records within the NSLDS reporting submissions. To further strengthen oversight and prevent recurrence, the Office of Student Financial Aid will implement documented post-submission reconciliation procedures following National Student Clearinghouse reporting cycles. These reviews will focus on high-risk enrollment reporting elements, including campus changes, program status changes, and other updates affecting NSLDS reporting, and will validate the accuracy of OPEID assignments and program-level effective dates against institutional records.